status: 200
encoding: ISO-8859-1
Date: Tue, 20 May 2025 04:42:09 GMT
Content-Type: text/xml
Transfer-Encoding: chunked
Connection: keep-alive
Strict-Transport-Security: max-age=31536000; preload
Last-Modified: Mon, 24 Mar 2025 12:25:22 GMT
X-Content-Type-Options: nosniff
X-Permitted-Cross-Domain-Policies: none
Content-Security-Policy: default-src 'self'  https://analytics.govinfo.gov https://stackpath.bootstrapcdn.com https://maxcdn.bootstrapcdn.com; frame-ancestors 'self'; script-src 'unsafe-inline' 'unsafe-eval' 'self'   https://stackpath.bootstrapcdn.com https://api.data.gov https://maxcdn.bootstrapcdn.com https://www.google.com/recaptcha https://recaptcha.google.com/recaptcha; object-src 'unsafe-inline' 'self' ; style-src 'unsafe-inline' 'self' https://cdn.jsdelivr.net https://maxcdn.bootstrapcdn.com https://api.data.gov  https://stackpath.bootstrapcdn.com https://fonts.googleapis.com https://www.google.com/recaptcha https://recaptcha.google.com/recaptcha; img-src 'unsafe-inline' 'self' http://insideanalytics.gpo.gov https://maxcdn.bootstrapcdn.com https://stackpath.bootstrapcdn.com  https://analytics.govinfo.gov data:; font-src 'unsafe-inline' 'self' https://cdn.jsdelivr.net https://stackpath.bootstrapcdn.com https://api.data.gov https://maxcdn.bootstrapcdn.com https://fonts.gstatic.com https://fonts.googleapis.com; connect-src 'self' https://api.data.gov https://analytics.govinfo.gov; frame-src 'self'  https://stackpath.bootstrapcdn.com https://maxcdn.bootstrapcdn.com https://www.google.com/recaptcha https://recaptcha.google.com/recaptcha;
cf-cache-status: DYNAMIC
Server: cloudflare
CF-RAY: 94292a6f5cfc620e-ORD
Content-Encoding: gzip

<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>340</number>
    <updateDate>2025-03-21T16:30:20Z</updateDate>
    <updateDateIncludingText>2025-03-21T16:30:20Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2025-01-13</introducedDate>
    <congress>119</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 171, Number 6 (Monday, January 13, 2025)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. CRENSHAW:H.R. 340.Congress has the power to enact this legislation pursuantto the following:Section 8 of article I of the Constitution.[Page H112]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-01-13T17:02:45Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <congress>119</congress>
        <number>1082</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2025-02-06</actionDate>
          <text>Referred to the House Committee on Energy and Commerce.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2025-01-13</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2025-01-13</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2025-01-13</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>C001120</bioguideId>
        <fullName>Rep. Crenshaw, Dan [R-TX-2]</fullName>
        <firstName>Dan</firstName>
        <lastName>Crenshaw</lastName>
        <party>R</party>
        <state>TX</state>
        <district>2</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>B001300</bioguideId>
        <fullName>Rep. Barragán, Nanette Diaz [D-CA-44]</fullName>
        <firstName>Nanette</firstName>
        <lastName>Barragán</lastName>
        <party>D</party>
        <state>CA</state>
        <middleName>Diaz</middleName>
        <district>44</district>
        <sponsorshipDate>2025-01-13</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2025-02-13T16:23:34Z</updateDate>
        </item>
        <item>
          <name>Cell biology and embryology</name>
          <updateDate>2025-02-13T16:22:57Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2025-02-13T16:23:43Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2025-02-13T16:23:38Z</updateDate>
        </item>
        <item>
          <name>Government information and archives</name>
          <updateDate>2025-02-13T16:23:13Z</updateDate>
        </item>
        <item>
          <name>Health information and medical records</name>
          <updateDate>2025-02-13T16:23:18Z</updateDate>
        </item>
        <item>
          <name>Internet, web applications, social media</name>
          <updateDate>2025-02-13T16:23:06Z</updateDate>
        </item>
        <item>
          <name>Organ and tissue donation and transplantation</name>
          <updateDate>2025-02-13T16:23:01Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2025-02-13T15:30:14Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2025-01-13</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2025-03-21T16:27:58Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;The HCT/P Modernization Act of 2025&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill requires the Food and Drug Administration (FDA) to provide information to stakeholders and report&amp;nbsp;on the regulation of human cell and tissue products, also referred to as&amp;nbsp;human cells, tissues, or cellular or tissue-based products (HCT/Ps), which are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.&lt;/p&gt;&lt;p&gt;The bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion with them on advancing the science and regulation of human cell and tissue products.  The FDA must establish a public docket to receive written comments on this topic, and submit to Congress a report with recommendations on regulating these products.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Additionally,  the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group and best practices for obtaining a recommendation about products from them. Also, annually for three years, the FDA must publish on its website information on the inquiries submitted and average response times for the Tissue Reference Group, as well as the number of human  cell and&amp;nbsp;tissue manufacturers that have&amp;nbsp;registered with the FDA and the number of inspections the FDA has conducted with respect to these manufacturers since 2019.  (The Tissue Reference Group is a working group within the FDA that receives product-specific questions from, and provides recommendations for, stakeholders on the regulation of human cell and tissue products under the FDA’s rules.)&amp;nbsp;&lt;br/&gt;&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>The HCT/P Modernization Act of 2025</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>The HCT/P Modernization Act of 2025</title>
        <updateDate>2025-02-11T05:53:21Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>The HCT/P Modernization Act of 2025</title>
        <updateDate>2025-02-11T05:53:19Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To direct the Secretary of Health and Human Services carry out activities to streamline regulatory oversight of human cell and tissue products, and for other purposes.</title>
        <updateDate>2025-02-11T05:48:28Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2025-01-13T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119hr340ih/xml/BILLS-119hr340ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-01-13</actionDate>
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
